Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Kesselheim, A. S. & Avorn, J. The most transformative drugs of the past 25 years: a survey of physicians. Nat. Rev. Drug Discov. 12, 425–431 (2013).
2. Center for Drug Evaluation. National Medical Products Administration. Annual Drug Evaluation Report https://www.cde.org.cn/main/news/viewInfoCommon/f92b7bdf775bbf4c4dc3a762f343cdc8 (2021).
3. Zhang, Y. et al. Overall survival benefits of cancer drugs approved in China from 2005 to 2020. JAMA Netw. Open 5, e2225973 (2022).
4. Li, G., Qin, Y., Xie, C., Wu, Y. L. & Chen, X. Trends in oncology drug innovation in China. Nat. Rev. Drug Discov. 20, 15–16 (2021).
5. Kesselheim, A. S., Wang, B. & Avorn, J. Defining “innovativeness” in drug development: a systematic review. Clin. Pharmacol. Ther. 94, 336–348 (2013).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献